1990 United States Supreme Court case
Eli Lilly & Co. v. Medtronic, Inc. Full case name Eli Lilly and Company v. Medtronic , Inc.Docket no. 89-243 Citations 496 U.S. 661 (more ) Prior Judgment for plaintiff, 696 F. Supp. 1033 (E.D. Pa. 1988); reversed, 872 F.2d 402 (Fed. Cir. 1989); rehearing en banc denied, 879 F.2d 849 (Fed. Cir. 1989); cert . granted, 493 U.S. 889 (1989). Subsequent Rehearing Denied, August 14, 1990, 1990 U.S. LEXIS 3730; remanded to District Court, 915 F.2d 670 (1990). Section 271(e)(1) exempts from infringement the use of patented inventions reasonably related to the development and submission of information needed to obtain marketing approval of medical devices under the FDCA.
Chief Justice
William Rehnquist
Associate Justices
William J. Brennan Jr. · Byron White Thurgood Marshall · Harry Blackmun John P. Stevens · Sandra Day O'Connor Antonin Scalia · Anthony Kennedy
Majority Scalia, joined by Rehnquist, Brennan, Marshall, Blackmun, Stevens Dissent Kennedy, joined by White O'Connor took no part in the consideration or decision of the case. 35 U.S.C. § 271
Eli Lilly and Company v. Medtronic , Inc. , 496 U.S. 661 (1990), is a United States Supreme Court case related to patent infringement in the medical device industry. It held that 35 U.S.C. § 271 (e)(1)[ 1] of United States patent law exempted premarketing activity conducted to gain approval of a device under the Federal Food, Drug, and Cosmetic Act from a finding of infringement.[ 2]
See also
References
External links
Subsidiaries People Products Legal cases